MH-3924A Cells

The MH3924A cell line is a well-characterized model derived from Morris rat hepatoma 3924A, which is frequently used in research to study hepatocellular carcinoma (HCC). These cells have been extensively employed to investigate the mechanisms underlying HCC growth, metastasis, and therapeutic responses. In particular, MH3924A cells are noted for their robust proliferative capacity and their ability to invade surrounding tissues, making them a suitable in vitro and in vivo model for exploring cancer progression and potential treatments.
Studies have demonstrated that the proliferation and invasiveness of MH3924A cells can be significantly influenced by various factors. For instance, treatment with the immunosuppressive drug tacrolimus (FK506) has been shown to promote the proliferation of these cells, enhance their invasive potential, and increase the expression of key molecules involved in metastasis, such as CXCR4 and its ligand SDF-1α. FK506’s effect on these cells underscores its potential to exacerbate cancer progression, particularly in the context of post-transplantation immunosuppression, where its use is common to prevent organ rejection but may inadvertently promote tumor growth.
Additionally, MH3924A cells have been genetically modified to express the human sodium/iodide symporter (hNIS), which significantly enhances their iodide uptake capability. This modification has facilitated the use of these cells in radioiodine therapy studies, providing insights into the potential application of gene therapy for targeting HCC. However, despite the increased uptake, the rapid efflux of iodide from the cells suggests that further modifications or combined treatments are necessary to retain the radioactivity within the tumor cells for effective therapy. The MH3924A cell line thus remains a pivotal model in both basic and applied cancer research, particularly in the study of HCC’s molecular underpinnings and therapeutic strategies.